Nuwellis Inc vs Tempus AI — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Tempus AI trades at $49.01 (market cap $8.69B). The key difference: Tempus AI is far larger — about 7972.5× Nuwellis Inc's market cap, and Tempus AI is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | TEM | |
|---|---|---|
Market Cap | $1.09M | $8.69B |
Sector | Technology | Broad Market / Factor |
52-Week High | $527.46 | $103.25 |
52-Week Low | $2.80 | $42.37 |
Enterprise Value | -$722.58K | $9.37B |
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →